New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Mark Cuban: A Master Disrupter for American Health...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
High-speed imaging tracks live brain cell activity...
World is falling behind on UN's child mortality Sustainable ...
April 16,2026
Health literacy initiative improves discharge education, rea...
April 15,2026
Constipation is common, but with simple changes, you can man...
April 14,2026
Children and teenagers more open to meat free diets—but stru...
April 13,2026
3D-printed ATLAS platform helps model cancer cell clusters b...
April 12,2026
3 million-cell map shows menopause reshapes breast tissue, p...
April 11,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Researchers urge arthritis patients to give up smoking to help them live longer

Researchers urge arthritis patients to give up smoking to help them live longer

by University of ManchesterCredit: Artem Podrez from PexelsUniversity of Manchester-led research has found new evidence to suggest that, not only is smoking associated with earlier deaths i
Immunology & Rheumatology June 01,2024
Researchers urge arthritis patients to give up smoking to help them live longer

Researchers urge arthritis patients to give up smoking to help them live longer

by University of ManchesterCredit: Artem Podrez from PexelsUniversity of Manchester-led research has found new evidence to suggest that, not only is smoking associated with earlier deaths i
Immunology & Rheumatology June 01,2024
Risk factors ID'd for VTE, ASCVD in rheumatoid arthritis patients

Risk factors ID'd for VTE, ASCVD in rheumatoid arthritis patients

(HealthDay)—For patients with rheumatoid arthritis (RA), there are common risk factors for venous thromboembolism (VTE) and atherosclerotic cardiovascular disease (ASCVD), and the risk for ASCVD is in
Immunology & Rheumatology June 01,2024
Risk factors ID'd for VTE, ASCVD in rheumatoid arthritis patients

Risk factors ID'd for VTE, ASCVD in rheumatoid arthritis patients

(HealthDay)—For patients with rheumatoid arthritis (RA), there are common risk factors for venous thromboembolism (VTE) and atherosclerotic cardiovascular disease (ASCVD), and the risk for ASCVD is in
Immunology & Rheumatology June 01,2024
Women with rheumatoid arthritis more likely to achieve remission if they take sex hormones, finds research

Women with rheumatoid arthritis more likely to achieve remission if they take sex hormones, finds research

by University of South AustraliaGraphical abstract. Credit:Rheumatology(2022). DOI: 10.1093/rheumatology/keac357A large study of women with rheumatoid arthritis has found that those t
Immunology & Rheumatology June 01,2024
Women with rheumatoid arthritis more likely to achieve remission if they take sex hormones, finds research

Women with rheumatoid arthritis more likely to achieve remission if they take sex hormones, finds research

by University of South AustraliaGraphical abstract. Credit:Rheumatology(2022). DOI: 10.1093/rheumatology/keac357A large study of women with rheumatoid arthritis has found that those t
Immunology & Rheumatology June 01,2024
CVD risk factors tied to disease activity, disability in RA

CVD risk factors tied to disease activity, disability in RA

(HealthDay)—Cardiovascular disease (CVD) risk factors alone, or in combination, are associated with higher disease activity and disability in rheumatoid arthritis (RA), according to a study recently p
Immunology & Rheumatology June 01,2024
CVD risk factors tied to disease activity, disability in RA

CVD risk factors tied to disease activity, disability in RA

(HealthDay)—Cardiovascular disease (CVD) risk factors alone, or in combination, are associated with higher disease activity and disability in rheumatoid arthritis (RA), according to a study recently p
Immunology & Rheumatology June 01,2024
Higher body temperatures still a factor in patients in remission from rheumatoid arthritis

Higher body temperatures still a factor in patients in remission from rheumatoid arthritis

by Staffordshire UniversityThermal image showing temperatures in the different regions of the foot. Credit: Staffordshire UniversityA pioneering study carried out among patients in remission from Rheu
Immunology & Rheumatology June 01,2024
Higher body temperatures still a factor in patients in remission from rheumatoid arthritis

Higher body temperatures still a factor in patients in remission from rheumatoid arthritis

by Staffordshire UniversityThermal image showing temperatures in the different regions of the foot. Credit: Staffordshire UniversityA pioneering study carried out among patients in remission from Rheu
Immunology & Rheumatology June 01,2024
Risankizumab safe, effective at 52 weeks for psoriatic arthritis

Risankizumab safe, effective at 52 weeks for psoriatic arthritis

by Lori SolomonRisankizumab provides long-term benefits in patients with psoriatic arthritis (PsA) who have not achieved adequate response to previous therapies, according to a study recently publishe
Immunology & Rheumatology June 01,2024
Risankizumab safe, effective at 52 weeks for psoriatic arthritis

Risankizumab safe, effective at 52 weeks for psoriatic arthritis

by Lori SolomonRisankizumab provides long-term benefits in patients with psoriatic arthritis (PsA) who have not achieved adequate response to previous therapies, according to a study recently publishe
Immunology & Rheumatology June 01,2024
Melanoma risk from biologic therapy remains uncertain

Melanoma risk from biologic therapy remains uncertain

(HealthDay)—Clinically important increases in melanoma risk in patients treated with biologic therapy for common inflammatory diseases cannot be ruled out based on current evidence, according to a rev
Dermatology June 01,2024
Melanoma risk from biologic therapy remains uncertain

Melanoma risk from biologic therapy remains uncertain

(HealthDay)—Clinically important increases in melanoma risk in patients treated with biologic therapy for common inflammatory diseases cannot be ruled out based on current evidence, according to a rev
Dermatology June 01,2024
When to see someone for your neck or back pain

When to see someone for your neck or back pain

by University of Colorado at BoulderCredit: centro güelAfter extended periods of research and computer work, you may be no stranger to neck and back pain. The daily wear and tear of graduate stud
Orthopedics & Sports medicine June 01,2024
When to see someone for your neck or back pain

When to see someone for your neck or back pain

by University of Colorado at BoulderCredit: centro güelAfter extended periods of research and computer work, you may be no stranger to neck and back pain. The daily wear and tear of graduate stud
Orthopedics & Sports medicine June 01,2024
Researchers link gut microbiome to rheumatoid arthritis prognosis

Researchers link gut microbiome to rheumatoid arthritis prognosis

by Susan Murphy,Mayo ClinicCredit: Pixabay/CC0 Public DomainA significant indicator of whether a patient with rheumatoid arthritis will improve over the course of disease may lie in part in thei
Immunology & Rheumatology June 01,2024
Researchers link gut microbiome to rheumatoid arthritis prognosis

Researchers link gut microbiome to rheumatoid arthritis prognosis

by Susan Murphy,Mayo ClinicCredit: Pixabay/CC0 Public DomainA significant indicator of whether a patient with rheumatoid arthritis will improve over the course of disease may lie in part in thei
Immunology & Rheumatology June 01,2024
Using meds to manage your arthritis pain: An overview

Using meds to manage your arthritis pain: An overview

by Cara MurezMillions of Americans suffer from arthritis, and many reach for medication to ease their joint pain and inflammation.The options might seem overwhelming, though. Here, the Arthritis Found
Orthopedics & Sports medicine June 01,2024
Using meds to manage your arthritis pain: An overview

Using meds to manage your arthritis pain: An overview

by Cara MurezMillions of Americans suffer from arthritis, and many reach for medication to ease their joint pain and inflammation.The options might seem overwhelming, though. Here, the Arthritis Found
Orthopedics & Sports medicine June 01,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu... ... Eye Infections (Updated) | Clinical Medicine ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com